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http://dxObjectives: Postoperative atrial fibrillation (POAF) complicating general thoracic surgery is a marker of in-
creased morbidity and stroke risk. Our goal was to determine whether increased preoperative brain natriuretic
peptide (BNP) levels are able to stratify patients by the risk of POAF.
Methods: Using a prospective database of 415 patients aged 60 years or older, who had undergone lung or
esophageal surgery during a 1-year period, the preoperative clinical data, including BNP levels, were compared
between patients who developed POAF lasting longer than 5 minutes during hospitalization and those who did
not.
Results: POAF occurred in 65 (16%) of the 415 patients and was more frequent among patients who had un-
dergone esophagectomy or anatomic lung resection (22% or 58 of 269) compared with thosewho did not (5% or
7 of 146; P<.0001). After esophagectomy or anatomic lung resection, 46 (34%) of the 135 patients with BNP
levels greater than the median (30 pg/mL) developed POAF compared with only 12 (9%) of 134 patients with
BNP levels less than 30 pg/mL (P<.0001). The rates of POAF in patients undergoing other thoracic procedures
were low and not associated with the BNP levels. Multivariate logistic regression analysis showed that in pa-
tients undergoing esophagectomy or anatomic lung resection, older age (5-year increments, odds ratio [OR],
1.28; 95% confidence interval [CI], 1.01-1.61; P ¼ .04), male gender (OR, 2.61; 95% CI, 1.12-4.17;
P ¼ .02), and BNP level 30 pg/mL or greater (OR, 4.52; 95% CI, 2.19-9.32; P< .0001) were independent
risk factors for POAF. The length of hospital stay was significantly increased in patients who developed
POAF compared with those who did not (P<.0001).
Conclusions: Among patients undergoing anatomic lung resection or esophagectomy, increased age, male gen-
der, and preoperativeBNP level of 30 pg/mL or greater were significant risk factors for the development of POAF.
The identification of patients who are more likely to develop POAFwill allow the development of trials assessing
prevention strategies aimed at reducing this complication. (J Thorac Cardiovasc Surg 2012;144:1249-53)Postoperative atrial fibrillation (POAF) occurs in 18% of
patients after noncardiac thoracic surgery, with patient
age, male gender, and the extent of surgical resection known
to be independent risk factors.1,2 The mechanisms
implicated as predisposing after surgery to enhance
susceptibility to re-entrant arrhythmias such as POAF in-
clude altered sympathovagal balance, operative injury to au-
tonomic fibers, and/or oxidative and inflammatory changes.
We, and others, have recently shown that preoperative echo-
cardiographic indexes of atrial dysfunction are associated
with the risk of POAF after thoracic surgery.3,4
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Mbefore thoracic surgery, and, if performed, the special
measurements needed require significant expertise and
additional cost. In contrast, blood biomarkers are easy to
analyze. An accumulating body of published data has
illustrated that increased brain natriuretic peptide (BNP)
levels predict postoperative major adverse cardiovascular
events, in general,5 and for POAF, specifically.6-11 It is
unclear which preoperative natriuretic peptide provides
the best prognostication or which BNP level would stratify
patients for the risk of developing POAF. Thus, we studied
a cohort of patients undergoing thoracic surgery for lung
or esophageal cancer with prospectively obtained BNP
levels to assess the relative prognostic significance of
preoperative BNP in predicting the risk of POAF.
METHODS
With approval of the Memorial Sloan-Kettering Cancer Center institu-
tional review board, we reviewed the charts of 433 consecutive patients,
aged 60 years or older, who had undergone lung or esophageal surgery
from June 2009 to June 2010. These patients participated in a prospective
observational quality improvement project using an abnormal preoperative
BNP level as a suggested guide for the individual surgical team to identify
patients at greater risk of POAF, who might require longer telemetrydiovascular Surgery c Volume 144, Number 5 1249
Abbreviations and Acronyms
BNP ¼ brain natriuretic peptide
POAF ¼ postoperative atrial fibrillation
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Mmonitoring and rate control drugs such as diltiazem and/or metoprolol to
attenuate the incidence of POAF.12 The choice of drug and the dose and
length of administration were not controlled. Additional BNP samples in
the postoperative period were not measured, because others have shown
that the preoperative BNP level wasmore predictive of POAF than the post-
operative BNP levels.9 The primary clinical endpoint of the study was the
new onset of POAF lasting greater than 5 minutes during hospitalization
and detected by continuous telemetry (48-72 hours) or 12-lead electrocar-
diography if the patient developed clinically significant POAF after telem-
etry was discontinued.We excluded those patients (n¼ 18) whowere not in
sinus rhythm at the evaluation before surgery, those taking antiarrhythmic
drugs, and patients whose surgery was postponed. Previous work had dem-
onstrated that the risk of POAF after lung surgery was associated with the
extent of resection; therefore, for the purposes of analysis, we stratified the
patients into 2 groups: those undergoing anatomic resection and those un-
dergoing exploratory thoracotomy or wedge resection only. Postoperative
pain relief was provided to all patients undergoing esophagectomy or ana-
tomic lung resection by continuous administration of epidural opioid (usu-
ally hydromorphone and bupivacaine). After an overnight stay in the
postanesthesia care unit, the patients were transferred to the thoracic surgi-
cal floor on the first postoperative day. Major postoperative cardiac or pul-
monary complications were recorded throughout the hospital stay.
To determine the difference in clinical characteristics between patients
with and without POAF, univariate analysis was conducted using Student t
or the chi-square test. The data are presented as the mean standard devi-
ation, unless otherwise indicated.P values were computed for each variable
for all available data. The surgical duration was log transformed before
analysis. We examined 2 cutoffs for BNP (100 pg/mL, because this is
considered abnormal in our laboratory, and 30 pg/mL because this was
the median value of the study patients) as the predictors of risk of POAF
in those who had undergone anatomic lung or esophageal resection. Mul-
tivariate stepwise logistic regression analysis was used to identify the inde-
pendent risk factors of POAF only in those patients who had undergone
anatomic lung or esophageal resection. Variables with P .15 on univariate
analysis were included in the initial model. The area under the receiver op-
erating characteristic curve was calculated to measure the predictive power
of the identified parameters. The correlation between age and BNP was as-
sessed using Spearman’s correlation analysis. Statistical analysis was per-
formed with the software SAS, version 9.2 (SAS Institute, Cary, NC).
RESULTS
The clinical characteristics of the entire patient cohort are
listed in Table 1. POAF occurred in 65 (16%) of the 415 pa-
tients at a median of 2 days (range, 0-6) after surgery. The
incidence of POAF was greater among the 269 patients
who had undergone esophagectomy or anatomic lung resec-
tion (n ¼ 58; 22%) than in the 146 patients who did not
(n¼ 7; 5%; P<.0001). The patient characteristics, surgical
data, and POAF incidence for those who had undergone
nonanatomic lung resection using a median BNP level of
30 pg/mL as the cutoff are listed in Table 2. The patients
whose BNP level was greater than the median were older
(P ¼ .01), had more coronary artery disease (P ¼ .05),
and more were taking b-blockers preoperatively (P ¼ .01)1250 The Journal of Thoracic and Cardiovascular Surthan those with a BNP less than the median (Table 2).
Among the patients who had undergone nonanatomic
lung resection, the mean BNP level did not differ between
those with and without POAF (48  59 vs 48  93 pg/
mL; P ¼ .75) nor by the BNP median cutoff level
(Table 2). Therefore, we excluded the patients who had
undergone nonanatomic lung resection from the prognostic
factor analysis. The patient characteristics and surgical data
of those who had undergone esophagectomy or anatomic
lung resection are presented in Table 3. On univariate anal-
ysis (Table 2), the patients who developed POAFwere more
likely to be men (P ¼ .02). They were, on average, older
than those who did not develop POAF (P ¼ .0002), had
hypertension (P ¼ .02), used preoperative b-blockers
(P ¼ .001), had a higher baseline BNP level (P<.0001),
and underwent pneumonectomy (global chi-square test,
P ¼ .04; pneumonectomy vs all other operations,
P¼ .02; no significant difference in POAF rate for the other
operations, P ¼ .59). The incidence of POAF was similar
whether video-assisted thoracic surgery or standard open
thoracotomy was done for anatomic lung resection. The
use of postoperative metoprolol or diltiazem in the immedi-
ate postoperative period did not affect the incidence of
POAF and was not confounded by the preoperative BNP
level. Using the BNP level of 100 pg/mL to stratify patients,
14 (48%) of 29 patients with a BNP level of 100 pg/mL or
greater developed POAF and 44 (18%) of 240 with a BNP
level less than 100 pg/mL had POAF. However, using the
median BNP level of 30 pg/mL to stratify the patients im-
proved the prediction, with POAF developing in 46
(34%) of 135 patients with a BNP level of 30 pg/mL or
greater but in only 12 (9%) of 134 with a BNP level of
less than 30 pg/mL (P<.0001).
Seven variables (age, male gender, hypertension, coro-
nary artery disease, preoperative use of b-blockers, BNP di-
chotomized at the median level of 30 pg/mL, and
pneumonectomy) with P  .15 on univariate analysis
were considered candidates for the multivariate logistic re-
gression analysis. That analysis showed that older age, male
gender, and BNP level of 30 pg/mL or greater were indepen-
dent risk factors associated with POAF (Table 4). The area
under the receiver operating curve for this model was 0.75,
and the Hosmer-Lemeshow goodness-of-fit statistic was
P ¼ .89. By Spearman correlation analysis, older age was
significantly associated with a greater BNP level
(r ¼ 0.35, P<.0001). The length of hospital stay was sig-
nificantly increased among patients who developed POAF
(median, 8 days; range, 1-52 compared with those who
did not (median, 5 days; range, 3-84; P<.0001).
An exploratory analysis of the clinical characteristics of
the 58 patients who developed POAF after esophagectomy
or anatomic lung resection was performed to compare those
with BNP levels greater than and less than the median
(Table 5). Patients with a BNP level of 30 pg/mL or moregery c November 2012
TABLE 1. Summary of patient characteristics (n ¼ 415)
Characteristic Value
Age (y) 70  7
Male gender 223 (54)
Preoperative heart rate>72 beats/min 196 (47)
Diabetes 62 (15)
Coronary artery disease 85 (20)
Hypertension 248 (60)
Smoking 331 (80)
Chemotherapy 117 (28)
Preoperative b-blocker use 138 (33)
Preoperative calcium channel blocker use 31 (8)
Preoperative statin use 155 (37)
BNP (pg/mL) 47  67
Surgical procedure
Esophagectomy 43 (10)
Lobectomy 191 (46)
Pneumonectomy 11 (3)
Segmentectomy 24 (6)
Nonanatomic resection 146 (35)
Data presented as mean  SD or n (%). BNP, Brain natriuretic peptide.
TABLE 3. Characteristics of patients who underwent anatomic
resection
Variable
No POAF
(n ¼ 211)
POAF
(n ¼ 58)
P
value
Age (y) 70  7 73  7 .0002
Male gender 110 (52) 40 (69) .02
Preoperative heart rate>72 beats/min 90 (43) 24 (41) .86
Diabetes mellitus 29 (14) 10 (17) .50
Coronary artery disease 41 (19) 17 (29) .11
Hypertension 122 (58) 43 (74) .02
Smoking 178 (84) 48 (83) .77
Chemotherapy 54 (26) 18 (31) .41
Preoperative b-blocker use 61 (29) 30 (52) .001
Preoperative calcium channel
blocker use
46 (22) 10 (17) .58
Preoperative statin use 83 (39) 21 (36) .66
BNP (pg/mL) 39  44 70  58 <.0001
Surgery duration (min) 218  92 256  122 .055
Surgical procedure
Esophagectomy 32 (15) 11 (19) .04*
Lobectomy 154 (73) 37 (64)
Pneumonectomy 5 (2) 6 (10)
Segmentectomy 20 (10) 39 (7)
VATS 67 (37) 15 (32) .48
Postoperative metoprolol use 152 (72) 46 (79) .27
Postoperative diltiazem use 46 (22) 10 (17) .45
Data presented as mean  SD or n (%). VATS, Video-assisted thoracic surgery for
lung resection; POAF, postoperative atrial fibrillation; BNP, brain natriuretic peptide.
*By global test; pneumonectomy versus all other operations, P ¼ .02.
Amar et al Perioperative Managementwere older (P ¼ .07) and had a much greater BNP level
(P<.0001) but did not differ in the other clinical variables
or the length of hospital stay.
DISCUSSION
POAF occurred in 22% of patients undergoing anatomic
lung or esophageal resection and was associated withTABLE 2. Nonanatomic lung resection patients and median BNP as
cutoff level
Variable
BNP 30 pg/mL
(n ¼ 71)
BNP<30 pg/mL
(n ¼ 75)
P
value
Age (y) 71  8 68  6 .01
Male gender 35 (48) 38 (52) .50
Preoperative heart rate
(beats/min)
73  14 76  12 .17
Diabetes 13 (13) 10 (18) .49
Coronary artery disease 18 (25) 9 (12) .05
Hypertension 44 (62) 39 (52) .25
Smoking 55 (78) 50 (67) .15
Chemotherapy 19 (27) 26 (35) .30
Preoperative b-blocker use 32 (45) 15 (20) .01
Preoperative calcium
channel blocker use
8 (11) 3 (4) .10
Preoperative statin use 27 (38) 24 (32) .45
Surgery duration (min) 116  64 125  68 .37
Surgical procedure
Wedge resection 45 (63) 51 (68) .56
Biopsy 26 (37) 24 (32)
Postoperative metoprolol 51 (72) 46 (61) .20
Postoperative diltiazem 6 (8.5) 11 (15) .19
POAF 3 (4) 4 (5) .89
Data presented as mean  SD or n (%). BNP, Brain natriuretic peptide; POAF, post-
operative atrial fibrillation.
The Journal of Thoracic and Cara longer hospital stay. The incidence of POAF was similar
whether video-assisted thoracic surgery or standard open
thoracotomy was used for anatomic lung resection. The
main findings of our study were that in patients undergoing
esophagectomy or anatomic lung resection, older age, male
gender, and increasing preoperative BNP are important in-
dependent risk factors for POAF, with BNP the strongest.
A joint model incorporating these 3 risk factors indicated
moderate predictive ability supporting the premise that
POAF has a multifactorial etiology. Patients with a BNP
level of 30 pg/mL or greater had a near fourfold increased
risk of POAF compared with those with a BNP level less
than the median cutoff. The BNP levels did not stratify pa-
tients undergoing nonanatomic resection by the risk of
POAF. The patients with POAF with elevated BNP levels
did not have clinical signs of congestive heart failure, sug-
gesting ‘‘subclinical’’ signs of left atrial distension or myo-
cardial dysfunction. This is consistent with recent work inTABLE 4. Multivariate analysis of risk factors for POAF
Variable OR 95% CI P value
Age (per 5-y increment) 1.28 1.01-1.61 .04
Male gender 2.16 1.12-4.17 .02
BNP 30 pg/mL 4.52 2.19-9.32 <.0001
BNP, Brain natriuretic peptide; CI, confidence interval; OR, odds ratio; POAF, post-
operative atrial fibrillation.
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TABLE 5. Subgroup analysis of patients with POAF and BNP cutoff
Variable
BNP 30 pg/mL
(n ¼ 46)
BNP<30 pg/mL
(n ¼ 12)
P
value
Age (y) 74  7 70  6 .07
Male gender 30 (65) 10 (83) .31
Preoperative heart rate
(beats/min)
71  14 70  8 .98
Diabetes 7 (15) 3 (25) .42
Coronary artery disease 15 (33) 2 (17) .48
Hypertension 33 (72) 10 (83) .71
Smoking 38 (83) 10 (83) .99
Chemotherapy 15 (33) 3 (25) .74
Preoperative b-blocker use 26 (57) 4 (33) .15
Preoperative calcium
channel blocker use
6 (13) 0 (0) .33
Preoperative statin use 17 (37) 4 (33) .81
Surgical procedure .48
Esophagectomy 9 (20) 2 (17)
Lobectomy 30 (65) 7 (58)
Pneumonectomy 5 (11) 1 (8)
Segmentectomy 2 (4) 2 (17)
Postoperative
metoprolol use
37 (80) 9 (75) .70
Postoperative diltiazem use 6 (13) 4 (33) .19
Data presented as mean  SD or n (%). BNP, Brain natriuretic peptide; POAF, post-
operative atrial fibrillation.
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Mwhich, using echocardiographic methods such as the inte-
grated left atrial volume and left atrial emptying fraction,
we showed that patients with POAF have signs of left atrial
distension and mechanical dysfunction.4 In previous work,
we devised a clinical prediction rule and point score for
POAF risk using the easily available preoperative clinical
characteristics of age older than 55 years, male gender,
and preoperative heart rate greater than 72 beats/min, with
age as the most important risk factor.2 In contrast to that ear-
lier study, in the present cohort of patients, the preoperative
heart rate did not discriminate patients likely to develop
POAF, possibly because among those with POAF, preoper-
ative hypertension and a greater use of b-blockers were
more prevalent. It is likely that the high use of postoperative
metoprolol in this cohort was reflective of a trend in many
institutions in the period in which these patients underwent
surgery to prophylactically administer these medications to
reduce overall perioperative cardiovascular morbidity, not
limited to POAF.
Our data are consistent with previous work by other in-
vestigators. Cardinale and colleagues9 evaluated more
than 400 patients undergoing thoracic surgery for lung can-
cer. They showed that in patients who developed POAF, the
pre- and postoperative N-terminal pro-BNP values were
significantly greater than in those patients who did not de-
velop POAF.9 Although N-terminal pro-BNP might have
a longer half-life, it is more affected by age, gender, and re-
nal function than BNP.13 Interestingly, in a smaller study,
Nojiri and colleagues10 found that a median BNP cutoff1252 The Journal of Thoracic and Cardiovascular Surof greater than 30 pg/mL was also a significant predictor
of POAF in 80 patients undergoing lung resection. Gibson
and colleagues11 reported that a BNP level greater than 30
pg/mL and a N-terminal pro-BNP level greater than 74
pg/mL were similarly predictive of POAF in 275 patients
undergoing coronary artery bypass grafting. Traditionally,
elevated atrial natriuretic peptides have been demonstrated
in patients with heart failure and either ventricular or atrial
wall distension. However, BNP can increase with chronic
conditions that include aging, atrial fibrosis, and inflamma-
tion, factors also known to contribute to POAF occurrence
without clinical evidence of cardiac wall stretch or heart
failure.13
In a pneumonectomy model of young and old dogs, we
found neutrophil cell infiltration of the atrial myocardium
in the older dogs, which were more prone to develop post-
pneumonectomy arrhythmias than were the younger dogs
without this finding.14 We also examined whether systemic
inflammation contributed to POAF but could not demon-
strate greater levels of plasma C-reactive protein among
the patients who developed POAF.15 In cardiac surgical pa-
tients, others have shown local myocardial, but not sys-
temic, evidence of inflammation in experimental animals
and in patients with POAF.16,17 Together with our results,
these studies suggest that the presence of preoperative
subclinical left atrial dysfunction before surgery, as
measured using echocardiography or elevated BNP levels,
contribute to postoperative myocardial systemic
inflammation and altered sympathovagal balance
necessary to initiate POAF in older patients undergoing
major thoracic surgery.14-17
Study Limitations
The patients selected for the present study were 60 years
or older, targeting those at greater risk of POAF. Although
our conclusions might not be applicable to younger patients,
most patients who undergo surgery for lung or esophageal
cancer will be within our study population’s age range.
Our rationale for including esophagectomy patients was
based on similar POAF rates in anatomic lung resection pa-
tients.2 We also included those who underwent lung resec-
tion by video-assisted thoracic surgery, because the
incidence of POAF is similar.18 Nevertheless, the character-
istics and clinical outcomes of the patients in the present
study population were very similar to others from single-
center studies comparable to ours.1,2 Although no patient
was excluded because they had a history of heart failure
or severe valvular heart disease, these are uncommon
conditions in the population of patients referred to our
institution for thoracic surgery.
CONCLUSIONS AND CLINICAL IMPLICATIONS
We found an association linking POAF in patients aged
60 years or older undergoing major lung or esophagealgery c November 2012
Amar et al Perioperative Managementcancer resection and an elevated preoperative BNP level,
with the median of 30 pg/mL working better as a cutoff.
Age, male gender, and increasing BNP are quantifiable
risk factors that are easily available before surgery to the
anesthesiologist, surgeon, and cardiologist. The use of
a BNP cutoff of 30 pg/mL or greater might help in identi-
fying a subset of patients at the greatest risk of developing
POAF who would most benefit from stratified prophylactic
interventions and careful observation. From these results,
we have modified our practice to incorporate preoperative
BNP for patients scheduled for major resections and con-
sider diltiazem prophylaxis when the BNP level is 30 pg/
mL or greater.12 Traditional antiarrhythmic drugs, how-
ever, have a modest success rate in reducing POAF and
could have untoward effects.12,19 In a pilot study, Nojiri
and colleagues20 used a BNP level of 30 pg/mL or greater
to stratify patients before lung resection and almost ironi-
cally showed that giving human atrial natriuretic peptide to
patients significantly reduced the rate of POAF. Human
atrial natriuretic peptide is used for treatment of heart
failure in some countries but has not been approved by
the U.S. Food and Drug Administration. We propose
that this novel approach of using the BNP cutoff of
30 pg/mL to target patients at high risk of POAF be incor-
porated in future editions of practice prevention guide-
lines.21 Subsequent randomized, controlled trials should
test traditional and nontraditional prevention strategies
using preoperative BNP.
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